HIF1A and lung cancer: Hypoxia was further characterized in different preclinical models of BM from lung cancers (H2030-Br3M, H1915; via intracerebral and intracardiac injections) using immunohistological staining (pimonidazole, HIF-1α) as well as imaging approaches.